AP NEWS
ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

John H. Noseworthy, M.D., Joins UnitedHealth Group Board of Directors

February 13, 2019 GMT

MINNETONKA, Minn.--(BUSINESS WIRE)--Feb 13, 2019--The board of directors of UnitedHealth Group (NYSE: UNH) announced John H. Noseworthy, M.D., has joined the board.

Stephen J. Hemsley, executive chairman of the board of directors of UnitedHealth Group, said: “John Noseworthy has served health care as an exceptionally talented and compassionate physician, a leading neurological researcher and educator, and as CEO of one of the most widely recognized and admired health systems in the United States and worldwide, Mayo Clinic. His leadership has been decisive in Mayo’s achievement of consistently high performance in health care quality, safety, research and finance, while championing wide-ranging improvements in the health care experience for both patients and physicians. John is an innovator whose early advocacy for more integrated health delivery supported by the latest technology has been combined with a dedication to maintaining and enhancing the care experience for patients. We welcome his expertise as UnitedHealth Group works to improve the future of health care.”

Dr. Noseworthy served as president and CEO of Mayo Clinic from 2009 until his retirement in 2018, leading one of the largest and most prestigious academic health systems in the United States, with $12 billion in annual revenues and 68,000 employees. With a focus on caring for patients with serious, complex illnesses, Mayo Clinic operates in five states and cares for more than 1 million people a year, from all 50 states and nearly 140 countries. Mayo Clinic is ranked No. 1 in the nation by U.S. News & World Report. Prior to his appointment as CEO, Dr. Noseworthy served as chair of Mayo Clinic’s Department of Neurology, medical director of the Department of Development and vice chair of the Mayo Clinic Rochester Executive Board.

Dr. Noseworthy received his M.D. degree from Dalhousie University in Halifax, Nova Scotia, Canada. He completed his neurology training at Dalhousie University and the University of Western Ontario, and a research fellowship at Harvard Medical School. He joined Mayo Clinic in 1990. He is the author of more than 150 research papers, chapters, editorials and several books, including the three-volume Neurological Therapeutics: Principles and Practice, now in its second edition. He also served as editor-in-chief of Neurology, the official journal of the American Academy of Neurology.

About UnitedHealth Group

ADVERTISEMENT

UnitedHealth Group (NYSE: UNH) is a diversified health care company dedicated to helping people live healthier lives and helping make the health system work better for everyone. UnitedHealth Group offers a broad spectrum of products and services through two distinct platforms: UnitedHealthcare, which provides health care coverage and benefits services; and Optum, which provides information and technology-enabled health services. For more information, visit UnitedHealth Group at www.unitedhealthgroup.com or follow @UnitedHealthGrp on Twitter.

Click here to subscribe to Mobile Alerts for UnitedHealth Group.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190213005221/en/

CONTACT: Tyler Mason

UnitedHealth Group

(424) 333-6122

KEYWORD: UNITED STATES NORTH AMERICA MINNESOTA

INDUSTRY KEYWORD: HEALTH FITNESS & NUTRITION HOSPITALS PROFESSIONAL SERVICES INSURANCE MEDICAL SUPPLIES GENERAL HEALTH

SOURCE: UnitedHealth Group

Copyright Business Wire 2019.

PUB: 02/13/2019 06:50 AM/DISC: 02/13/2019 06:50 AM

http://www.businesswire.com/news/home/20190213005221/en

ADVERTISEMENT